Forums

World MS Day 2024 "My MS Disagnosis" PART ONE
Presented 30 May 2024
FirstFrame Jessie Scott MS Advisory Group
Jodi Haartsen Brain Health in MS
Dr Emma Beckett Nutrition for Long Term Health
Dr Vick Maltby Updates in MS Research
Open access logo MS Advisory Group.
Open access logo MS Plus How can people with MS improve their sleep?
Open access logo Sleep Health Foundation
Open access logo Butzkueven, Helmut et al. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome . Brain : a journal of neurology vol. 147,4 (2024): 1206-1215. doi:10.1093/brain/awad409
Open access logo Barrie, W., Yang, Y., Irving-Pease, E.K. et al Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. Nature 625, 321–328 (2024). https://doi.org/10.1038/s41586-023-06618-z
Open access logo Xavier, Alexandre et al. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. Frontiers in immunology vol. 14 1162796. 30 May. 2023, doi:10.3389/fimmu.2023.1162796
World MS Day 2024 "My MS Disagnosis" PART TWO
Presented 30 May 2024
FirstFrame Sommer Walter MS Advisory Group
Jodi Haartsen Brain Health in MS
Dr Jeanette Lechner-Scott Updates in MS Therapies Pipeline
Dr Yasmine Probst and Olivia Wells Impact of Nutrition in MS
Open access logo MS Advisory Group.
Open access logo MS Plus How can people with MS improve their sleep?
Open access logo Sleep Health Foundation
Open access logo Håkansson I. Biomarkers and Disease Activity in Multiple Sclerosis: A cohort study on patients with clinically isolated syndrome and relapsing remitting multiple sclerosis. DOI:10.3384/diss.diva-160762
Open access logo Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296-301. doi:10.1126/science.abj8222.
Open access logo Maier HB, Stadler J, Deest-Gaubatz S, et al. The significance of cerebrospinal fluid analysis in the differential diagnosis of 564 psychiatric patients: Multiple sclerosis is more common than autoimmune-encephalitis Psychiatry Res. 2024;333:115725. doi:10.1016/j.psychres.2024.115725
Open access logo He A, Merkel B, Brown JWL, et al. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. Lancet Neurol. 2020;19(4):307-316. doi:10.1016/S1474-4422(20)30067-3.
Open access logo Dobson R, Rog D, Ovadia C, et al. Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. Pract Neurol. 2023;23(1):6-14. doi:10.1136/pn-2022-003426.
Open access logo Mowry EM, Azevedo CJ, McCulloch CE, et al. Body mass index, but not vitamin D status, is associated with brain volume change in MS. Neurology. 2018;91(24):e2256-e2264. doi:10.1212/WNL.0000000000006644.
Open access logo Tredinnick AR, Probst YC. Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review. Adv Nutr. 2020;11(6):1603-1615. doi:10.1093/advances/nmaa063.
Open access logo Wills O, Wright B, Greenwood LM, et al. Lifestyle management and brain MRI metrics in female Australian adults living with multiple sclerosis: a feasibility and acceptability study. Pilot Feasibility Stud. 2024;10(1):71. Published 2024 May 2. doi:10.1186/s40814-024-01495-3.
-

expand all/colapse all

+
03 April 2024
2024 HNELHD Falls Forum: "Better Balance for Healthy Ageing" and "Let's Get Up (to speed)"
21 March 2024
Closing the gap forum
01 March 2024
Deaf engagement forum
Multidisciplinary Trauma Forum
Single Digital Patient Record
04 September 2023
Women's Health Week 2023
01 September 2023
WHaM Forum: Change Through Innovation
03 August 2023
AI blackboxes, hallucinations and misinformation
30 June 2023
Stroke of change
16 March 2023
Closing the gap
09 February 2023
Darwin's theories... APSAD 2022 Feedback Forum
Moments that matter